Asahi Kasei Corp. is buying Denmark’s Veloxis Pharmaceuticals A/S for 143.2 billion yen ($1.3 billion), the companies said, in the latest of a series of deals by Japanese drugmakers. Sustainability ReportSustainability concepts and activities of the Asahi Kasei Group are described. One of its products is Fasudil, a drug which Asahi sought to market in the United States (U.S.) for treatment of pulmonary arterial hypertension (PAH).
Asahi Kasei Pharma America is committed to the continued advancement and ultimate success of ART-123 and we look forward to providing updates on the progress of this program.-Kazuhisa Tsuruta, Ph.D., President, Chief Executive Officer and Chief Scientific Officer of Asahi Kasei Pharma America. Development stage Code name, form, generic name Classifications Indication Region Origin Remarks; Phase III: AK1820, injection/capsule, isavuconazole: Antifungal agent It was founded in May 1931, using the paid in capital of Nobeoka Ammonia Fiber Co., Ltd, a Nobeoka, Miyazaki based producer of ammonia, nitric acid, and other chemicals. Asahi Kasei Pharma provides a range of pharmaceuticals and other health care-related products. Asahi Kasei Pharma Corporation (Asahi) is a Japanese corporation which develops and markets pharmaceutical products and medical devices. While further expanding our global-leading businesses, we provide high value-added products that meet emerging needs.

2012 Accelerating global business expansion. Purpose for Using Personal Information The purpose of using personal information provided to us is, in principle, only to respond to inquiries, to provide information related to products and services of Asahi Kasei Pharma Corp. and its affiliates (hereinafter the Asahi Kasei Group), and to improve products and services of the Asahi Kasei Group. ZOLL offers a comprehensive array of acute critical care products and has a firm global position in professional products for hospitals and emergency medical services. Businesses ranging from basic chemicals to functional materials and consumables are based on Asahi Kasei’s core chemical technology. Asahi Kasei Pharma (AKP) is a Japanese pharmaceutical company dedicated to research, development and commercializing innovative products for unmet medical needs in the areas of musculoskeletal disorders, including pain management, and critical care Corporate BrochureA brochure profiling the business operations of the Asahi Kasei Group. 旭化成制药将经营资源集中在医药业务领域，在骨科和泌尿科等重点领域研发全球通用的新药，力争成为有存在感、有特色的国际化制药公司。在诊断药领域，将经营资源集中投入到有增长潜力的产品中。 In April 2012, the Asahi Kasei Group acquired ZOLL Medical Corporation. Asahi Kasei Corporation (旭化成株式会社, Asahi Kasei Kabushiki-gaisha, styled as AsahiKASEI) is a multinational Japanese chemical company.Its main products are chemicals and materials science.. We pursue a broad approach to medicine to provide innovative and unique health care solutions. For Investors.
Intellectual Property ReportThe Asahi Kasei Group’s approach to R&D and intellectual property are described, as well as notable results.